E-Z-EM continues with cost-cutting initiative:
This article was originally published in Clinica
E-Z-EM is to move its powder-based barium production to its manufacturing facility in Montreal as part of its ongoing strategy to streamline its global production infrastructure. Lake Success, New York-based E-Z-EM, who develops contrast agents for gastrointestinal radiology, expects the move to take 12 months to complete and to generate annual pre-tax savings of around $2.2m. The charges incurred will be recorded over a 12-month period and are estimated on a pre-tax basis at $2.8m.